Epigenetic Modifiers in Myeloid Malignancies: The Role of Histone Deacetylase Inhibitors
Myeloid hematological malignancies are clonal bone marrow neoplasms, comprising of acute myeloid leukemia (AML), the myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), the myeloproliferative neoplasms (MPN) and systemic mastocytosis (SM). The field of epigenetic regulation of n...
Main Author: | Johanna S. Ungerstedt |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/19/10/3091 |
Similar Items
-
<i>NPM1</i>-Mutated Myeloid Neoplasms with <20% Blasts: A Really Distinct Clinico-Pathologic Entity?
by: Fabio Forghieri, et al.
Published: (2020-11-01) -
A pragmatic patient-reported outcome strategy for rare disease clinical trials: application of the EORTC item library to myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia
by: Jill A. Bell, et al.
Published: (2019-06-01) -
Systemic mastocytosis with associated acute myeloid leukemia with t (8; 21) (q22; q22)
by: V S Gadage, et al.
Published: (2012-01-01) -
Intertriginous maculopapular mastocytosis in a patient with acute myeloid leukemia
by: María Herrero-Moyano, MD, et al.
Published: (2017-01-01) -
Therapy related acute myeloid leukemia with t(10:16): a rare entity
by: Guldeep K. Uppal, et al.
Published: (2011-12-01)